Published

Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushrooms.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: British journal of pharmacology
Date: 2024-10-01
Source: PubMed
DOI: 10.1111/bph.16466
PubMed: 38825326

Authors

Rakoczy RJ Runge GN Sen AK Sandoval O Wells HG Nguyen Q Roberts BR Sciortino JH Gibbons WJ Friedberg LM Jones JA McMurray MS

Watch author

Derived topics and classifications

psilocybin psilocin Brain Imaging Pharmacology Receptor Pharmacology Biomarkers Aging In Vitro Study Safety In Vitro Study

Citation graph

0 referenced DOIs found in stored source metadata. 6 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats2026-10-01 In-silico toxicity study of tryptamine, psilocin, psilocybin, N,N-dimethyltryptamine, 5’-methoxy-N,N-dimethyltryptamine and O-acetylpsilocin2026-08-01 Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development2026-07-03 Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARA2026-06-15 Time to embrace the whole: considering the replacement of psilocybin with Psilocybe spp. in psychedelic research and therapy2026-06-02 Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushrooms.2024-10-01

Related papers

The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young AdultsClinicalTrials.gov · 2026-08-14 Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot StudyClinicalTrials.gov · 2026-08-10 Evaluating the Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant Obsessive-compulsive Disorder: An Open-label Clinical TrialClinicalTrials.gov · 2026-07-28 TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance TherapyClinicalTrials.gov · 2026-08-12 TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer SurvivorsClinicalTrials.gov · 2026-08-12 Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)ClinicalTrials.gov · 2026-07-30 A Randomized, Double-Blind, Placebo-Controlled Mechanistic Study to Assess a Single Oral Dose of CYB003 in Participants With Major Depressive Disorder (MDD) and Moderate to Severe AnxietyClinicalTrials.gov · 2026-07-23 A Randomized, Double-Blind, Single Ascending Dose Study to Identify a Safe and Non-Psychedelic Dose of PsilocybinClinicalTrials.gov · 2026-07-17